Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of aC-microtracer and therapeutic dose in cancer patients

L van Andel, H. Rosing, Z Zhang, L. Hughes, V Kansra, M Sanghvi, M. Tibben, A. Gebretensae, J H M Schellens, J H Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The article ''Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a14C-microtracer and therapeutic dose in cancer patients'', written by L. van Andel, H. Rosing, Z. Zhang, L. Hughes, V. Kansra, M. Sanghvi, M. M. Tibben, A. Gebretensae, J. H. M. Schellens and J. H. Beijnen, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 17th October 2017 without open access.

Original languageEnglish
Pages (from-to)47
JournalCancer Chemotherapy and Pharmacology
Volume81
Issue number1
Early online date17 Oct 2017
DOIs
Publication statusPublished - Jan 2018

Keywords

  • Published Erratum

Fingerprint

Dive into the research topics of 'Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of aC-microtracer and therapeutic dose in cancer patients'. Together they form a unique fingerprint.

Cite this